http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
a worldwide yearly survey of new data and trends
The Side Effects of Drugs Annual was first published in 1977. It has been continually published since then, as a yearly update to the voluminous encyclopedia Meyler's Side Effects of Drugs. Each new Annual continues to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of Adverse Drug Reactions and Interactions. An international team of specialists has contributed to the informative, by critically interpreting it, and by pointing to whatever is misleading. Provides a critical yearly survey of new data and trends in the side effects of drugs. Each drug article contains case histories. Contains detailed information on drug-drug interactions.
Front cover; Side Effects of Drugs Annual 30; Copyright page; Contributors; Contents; Special reviews; Cumulative indexes of special reviews, Annuals 13-29; Table of Essays, Annuals 1-29; DoTS classification of adverse drug reactions; How to use this book; Drug withdrawals because of adverse effects; Acknowledgement; References; Chapter 1. Central nervous system stimulants and drugs that suppress appetite; Amphetamines; Methylxanthines; Drugs that suppress appetite; Drugs used in Alzheimer's disease; References; Chapter 2. Antidepressant drugs; General; Tricyclic antidepressants
Selective serotonin re-uptake inhibitors (SSRIs)Serotonin and noradrenaline re-uptake inhibitors (SNRIs); Other antidepressants; References; Chapter 3. Lithium; The efficacy of lithium and comparisons with alternative agents; References; Chapter 4. Drugs of abuse; Cannabinoids; Cocaine; Fetotoxicity of cocaine; Epidemiology of the use of ecstasy; Khat; Opioid analgesics; References; Chapter 5. Hypnosedatives and anxiolytics; Benzodiazepines; Other hypnosedatives; References; Chapter 6. Antipsychotic drugs; General; Antipsychotic drugs in elderly patients; Individual drugs; References
Chapter 7. Antiepileptic drugsGeneral; Pregabalin; References; Chapter 8. Opioid analgesics and narcotic antagonists; Routes of administration of opioids; Opioid receptor agonists; Partial opioid receptor agonists; Opioid receptor antagonists; References; Chapter 9. Anti-inflammatory and antipyretic analgesics and drugs used in gout; Strategies to reduce upper gastrointestinal tract damage caused by non-steroidal anti-inflammatory drugs (NSAIDs); Individual drugs and classes; Aniline derivatives; Paracetamol and the risk of asthma; COX-2 selective inhibitors; Oxicams; Pyrazolone derivatives
Drugs used in the treatment of goutReferences; Chapter 10. General anesthetics and therapeutic gases; Anesthetic Vapors; Halogenated vapors; Other vapors; Intravenous agents: non-barbiturate anesthetics; Prevention of pain due to propofol injection; Intravenous agents: barbiturate anesthetics; References; Chapter 11. Local anesthetics; Effects related to modes of use; Individual compounds; References; Chapter 12. Neuromuscular blocking agents and skeletal muscle relaxants; Depolarizing neuromuscular blocking agents; Skeletal muscle relaxants; References
Chapter 13. Drugs that affect autonomic functions or the extrapyramidal systemDrugs that stimulate both alpha- and beta-adrenoceptors; Drugs that predominantly stimulate alpha1-adrenoceptors; Drugs that stimulate beta1-adrenoceptors; Drugs that stimulate dopamine receptors; Pathological gambling and dopamine receptor agonists; Ergot derivatives; Drugs that affect the cholinergic system; References; Chapter 14. Dermatological drugs, topical agents, and cosmetics; Cosmetics; Phototherapy and photochemotherapy; Sunscreens; Vitamin A (retinoids); Vitamin D analogues, topical; References
Drug-Related Side Effects and Adverse Reactions